Targeting TORC2 in multiple myeloma with a new mTOR kinase inhibitor

Although preclinical work with rapalogs suggests potential in treatment of multiple myeloma (MM), they have been less successful clinically. These drugs allostearically inhibit the mammalian target of rapamycin kinase primarily curtailing activity of the target of rapamycin complex (TORC)1. To asses...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hoang, Bao, Frost, Patrick, Shi, Yijiang, Belanger, Eileen, Benavides, Angelica, Pezeshkpour, Gholam, Cappia, Susanna, Guglielmelli, Tommasina, Gera, Joseph, Lichtenstein, Alan
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2010
Assuntos:
Lymphoid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2996116/
https://ncbi.nlm.nih.gov/pubmed/20686120
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2010-05-285726
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados